Drug intelligence / Profile preview

fenbendazole

Development stage
Unknown
Lead developer
Merck Animal Health
Modality
Small Molecules
Administration
Oral
01

Overview

Fenbendazole is a broad-spectrum benzimidazole anthelmintic used primarily in veterinary medicine to treat gastrointestinal parasites such as roundworms, hookworms, whipworms, certain tapeworms (Taenia genus), pinworms, strongyles, and giardia in animals including dogs, cats (off-label), horses, cattle, goats, rabbits, sheep and laboratory rodents. Its mechanism of action involves binding to beta-tubulin in parasite cells and disrupting microtubule formation. This disruption impairs cell division and glucose uptake by the parasite—ultimately leading to energy depletion and death of the parasite. Fenbendazole is poorly absorbed orally so it acts mainly within the gut lumen[1][2][3][5][6]. It is not approved for human use but has been discussed anecdotally for potential anti-cancer effects; however there are no clinical trials supporting its use for cancer therapy in humans[5].

Brand names
PanacurSafe-Guard
Other names
methyl N-(6-phenylsulfanyl-1H-benzimidazol-2yl)PanacurSafe-Guard
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on fenbendazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fenbendazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call